Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2013

Jul 31, 2013

29821_dirs_2013-07-31_ca5f00eb-8cb6-4ea8-8170-688a48f48805.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-07-29

Reporting Person: Onuscheck John Michael (SVP & President, EMEA)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2013-07-29 Common Stock M 4165.0000 $0.0000 Acquired 75995.0000 Direct
2013-07-29 Common Stock F 2202.0000 $10.9700 Disposed 73793.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2013-07-29 Deferred Stock Units $ M 4165.0000 Disposed Common Stock (4165.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on July 29, 2009, the first anniversary of the grant of the award.

F3: Reflects multiple DSU awards with independent vesting schedules.